Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:12:07.328Z.
Calculation as of: 2026-10-06T14:12:07.328Z.
Quote observation: 2026-10-06T14:10:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 325841a12d79c3b22e4488d0564adef7d4bfa7ba78e5cc1d4c3dcb4b1cd6f762
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$1.38M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.45M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.16M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.46M
Operating Cash Flow Yield
N/A
TTM Avg
2.09%
3Y Avg
2.09%
5Y Avg
2.09%
Market Cap
$1.45M
Operating Cash Flow Yield
N/A
TTM Avg
13.05%
3Y Avg
13.05%
5Y Avg
13.05%
Market Cap
$1.19M
Operating Cash Flow Yield
N/A
TTM Avg
48.56%
3Y Avg
48.84%
5Y Avg
48.84%
Market Cap
$1.46M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.11M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Genprex, Inc. (GNPX) | $1.31M | N/A | N/A | N/A | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | N/A | N/A | N/A | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.45M | N/A | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.16M | N/A | N/A | N/A | N/A |
| Curis, Inc. (CRIS)vs › | $1.46M | N/A | 2.09% | 2.09% | 2.09% |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | N/A | 13.05% | 13.05% | 13.05% |
| IM Cannabis Corp. (IMCC)vs › | $1.19M | N/A | 48.56% | 48.84% | 48.84% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | N/A | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.10M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
